- Home
- NTCL vs PRQR Comparison
NTCL vs PRQR Comparison
Compare NTCL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTCL
- PRQR
- Stock Information
- Founded
- NTCL 2003
- PRQR 2012
- Country
- NTCL China
- PRQR Netherlands
- Employees
- NTCL N/A
- PRQR N/A
- Industry
- NTCL
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- NTCL
- PRQR Health Care
- Exchange
- NTCL NYSE
- PRQR Nasdaq
- Market Cap
- NTCL 193.8M
- PRQR 179.1M
- IPO Year
- NTCL 2024
- PRQR 2014
- Fundamental
- Price
- NTCL $1.80
- PRQR $1.93
- Analyst Decision
- NTCL
- PRQR Strong Buy
- Analyst Count
- NTCL 0
- PRQR 7
- Target Price
- NTCL N/A
- PRQR $9.00
- AVG Volume (30 Days)
- NTCL 1.3M
- PRQR 288.1K
- Earning Date
- NTCL 01-01-0001
- PRQR 08-07-2025
- Dividend Yield
- NTCL N/A
- PRQR N/A
- EPS Growth
- NTCL N/A
- PRQR N/A
- EPS
- NTCL N/A
- PRQR N/A
- Revenue
- NTCL $10,101,647.00
- PRQR $21,212,711.00
- Revenue This Year
- NTCL N/A
- PRQR N/A
- Revenue Next Year
- NTCL N/A
- PRQR N/A
- P/E Ratio
- NTCL N/A
- PRQR N/A
- Revenue Growth
- NTCL N/A
- PRQR 85.91
- 52 Week Low
- NTCL $1.09
- PRQR $1.07
- 52 Week High
- NTCL $51.80
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- NTCL N/A
- PRQR 60.77
- Support Level
- NTCL N/A
- PRQR $1.77
- Resistance Level
- NTCL N/A
- PRQR $2.03
- Average True Range (ATR)
- NTCL 0.00
- PRQR 0.10
- MACD
- NTCL 0.00
- PRQR 0.01
- Stochastic Oscillator
- NTCL 0.00
- PRQR 72.97
About NTCL NETCLASS TECHNOLOGY INC
Netclass Technology Inc is a business-to-business smart education specialist, providing IT solutions to schools, training institutions, corporations, public agencies and other institutions or corporate customers. It offers SaaS subscription service and application development. The solution's modules include teaching management, campus management, online teaching, online examination, epidemic prevention and control, education credit blockchain system, and lecturer evaluation services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.